SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Encouraging Results from Phase2a Trial of SGX945 in Behcet’s Disease ...

Soligenix Inc. (NASDAQ:SNGX) shares surged on Thursday as the company announced positive results from its Phase 2a ...

Structural heart disease often shows no symptoms until it's too late, but Columbia's AI tool, EchoNext, can flag potential cases from routine ECGs that trained doctors might miss.

What treatments are available? While there’s no cure yet for Parkinson’s disease, there are several effective ways to treat the symptoms, and many promising drugs are in the pipeline that may ...

A rapidly spreading disease caused by tick bites has now found its way to Virginia, Maryland, West Virginia, and Washington, D.C., according to a study, published in the Journal of Medical ...

Crohn's disease is a serious inflammatory bowel disease (IBD) that impacts millions worldwide. The disease is chronic and highly unpredictable, manifesting symptoms such as abdominal pain ...

Study analyzing 77 research papers finds habitual consumption of processed foods increases chronic disease risk, challenging assumptions about safe levels.

Behçet’s disease (BD), a chronic, multisystem vasculitis, is best known for recurrent oral and genital ulcers, ocular inflammation, and skin lesions. Although more commonly diagnosed in adults, ...

The FDA has approved Gamifant as the first-ever treatment for macrophage activation syndrome in Still’s disease for adults and children who have an inadequate response or intolerance to ...

Health Why Lyme disease and other tick-borne conditions are on the rise Ticks are spreading globally and bringing familiar conditions such as Lyme disease with them, as well as totally new ones.

In the study, published Tuesday in the journal Heart, researchers found cannabis use is linked to a doubled risk of dying from cardiovascular disease, a 29% higher risk for acute coronary syndrome ...

The FDA has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer.